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Scientific objectives
Mental disorders affect up to 40 % of all individuals living
in Europe at least once a life time. Serious mental disor-
ders with chronic or relapsing course like major depres-
sion bipolar disorder and schizophrenia are disabling and
often disintegrating disorders. The early identification of
subjects being at risk for serious mental disorders holds
the promise of early intervention and better long-term
outcomes. However, still reliable early indicators are lar-
gely missing to date. Like in dementia research major
research initiatives need to be developed to address those
urgent issues.
Technological approaches
New MRI imaging technique, genotyping, gene methyla-
tion analyses, metabolom analyses, validated question-
naires for the assessment of psychosocial risk factors.
Results interpretation
Advanced statistical modeling of brain imaging data,
support vector machine approaches, systems integration
of OMICS data; data mining approaches for risk marker
identification.
Outlook and expert recommendations
The identification of peripheral risk indicators of severe
mental diseases is probably limited to rare but highly
penetrative genetic variants. Possibly gene-methylation
patterns that emerge in the light of abuse and traumati-
zation be constitute another source of valuable informa-
tion. The non-invasive MRI imaging technologies might
be very promising but still time consuming and expen-
sive. Especially functional MRI studies are only feasible
in specialist centers. The most promising approach
seems to create a set of specific markers throughout the
different levels of information to integrate biological,
psychosocial and structural information on each subject.
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